drugset
drugset / Trial / NCT07618299

Evaluation of the Excretion of Fosfomycin Into Breast Milk Following a Single Intravenous Dose of ZTI-01 (6 g) in Healthy Lactating Women

NCT07618299 ↗

Phase 4 Recruiting 24 enrolled Meitheal Pharmaceuticals, Inc.
NaSingle-groupOpen-labelOther

Summary

Evaluation of the Excretion of Fosfomycin into Breast Milk Following a Single Intravenous Dose of ZTI-01 (6 g) in Healthy Lactating Women

Timeline

Start
2026-09-22
Primary completion
2027-09
Completion
2027-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Fosfomycin Small molecule 6 g Intravenous

Indications

No indication recorded.